Home » Topics » BioWorld Science

BioWorld Science
RSS

AMBI acquires nutrition company

Aug. 25, 1997

Antiinflammatory selectin-binding peptides from Affymax

Aug. 25, 1997

Xoma discloses rBPI-Ig fusion proteins

Aug. 25, 1997

New nonpeptide substance P antagonist from Pfizer

Aug. 25, 1997

New D4 antagonist may aid in the search for antipsychotic drugs

Aug. 25, 1997

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Aug. 25, 1997

Microtubule inhibitor with low toxicity and unique profile of CaM activity

Aug. 25, 1997

Titan's Spheramine receives orphan drug designation

Aug. 25, 1997

Indomethacin prodrug with potent antiinflammatory effects, low ulcerogenicity

Aug. 25, 1997

Living human tissue approved for marketing in Canada

Aug. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...